DEA
BSX icon

DoubleLine ETF Adviser’s Boston Scientific BSX Stock Holding History

DoubleLine ETF Adviser’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Sell
17,556
-1,421
-7% -$77.2K 0.31% 89
2026
Q1 		$1.19M Buy
+18,977
New +$1.52M 0.45% 61

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DoubleLine ETF Adviser's BSX Position: Q2 2026 in Review

DoubleLine ETF Adviser reduced its Boston Scientific (BSX) stake by 7.5% in Q2 2026, selling an estimated $77.2K and leaving 17,556 shares worth $749K. The position accounts for 0.31% of the portfolio, ranked #89.

DoubleLine ETF Adviser first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.19M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • DoubleLine ETF Adviser held 17,556 shares of Boston Scientific worth $749K as of Q2 2026.
  • DoubleLine ETF Adviser sold 1,421 Boston Scientific shares in Q2 2026, an estimated $77.2K.
  • Boston Scientific made up 0.31% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #89 holding.
  • DoubleLine ETF Adviser first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • DoubleLine ETF Adviser's Boston Scientific position peaked at $1.19M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.